EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Histone deacetylase‐3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models

Nicola Davis iD, Ben Taylor, Laura Abelleira-Hervas iD, Najmeh Karimian-Marnani, Robertas Aleksynas iD, Nelofer Syed iD, Simone Di Giovanni iD, Ilaria Palmisano iD, Magdalena Sastre iD

The FASEB Journal · 31.05.2024 · 38 (10)

DOI: 10.1096/fj.202301762rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 11.05.2024. Verfasst von Nicola Davis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Protein Precursor, Histone Deacetylases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HDAC3 inhibition has been shown to improve memory and reduce amyloid‐β (Aβ) in Alzheimer's disease (AD) models, but the underlying mechanisms are unclear. We investigated the molecular effects of HDAC3 inhibition on AD pathology, using in vitro and ex vivo models of AD, based on our finding that HDAC3 expression is increased in AD brains. For this purpose, N2a mouse neuroblastoma cells as well as organotypic brain cultures (OBCSs) of 5XFAD and wild‐type mice were incubated with various concentrations of the HDAC3 selective inhibitor RGFP966 (0.1–10 μM) for 24 h. Treatment with RGFP966 or HDAC3 knockdown in N2a cells was associated with an increase on amyloid precursor protein (APP) and mRNA expressions, without alterations in Aβ42 secretion. In vitro chromatin immunoprecipitation analysis revealed enriched HDAC3 binding at APP promoter regions. The increase in APP expression was also detected in OBCSs from 5XFAD mice incubated with 1 μM RGFP966, without changes in Aβ. In addition, HDAC3 inhibition resulted in a reduction of activated Iba‐1‐positive microglia and astrocytes in 5XFAD slices, which was not observed in OBCSs from wild‐type mice. mRNA sequencing analysis revealed that HDAC3 inhibition modulated neuronal regenerative pathways related to neurogenesis, differentiation, axonogenesis, and dendritic spine density in OBCSs. Our findings highlight the complexity and diversity of the effects of HDAC3 inhibition on AD models and suggest that HDAC3 may have multiple roles in the regulation of APP expression and processing, as well as in the modulation of neuroinflammatory and neuroprotective genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-Protein PrecursorHistone DeacetylasesAnimalsMiceAcrylamidesAmyloid beta-PeptidesBrainCell Line, TumorDisease Models, AnimalHistone Deacetylase InhibitorsMice, Inbred C57BLMice, TransgenicMicrogliaPhenylenediaminesHistone Deacetylase 3

Stichwörter der Autor:innen

Alzheimer's diseaseamyloid‐βepigeneticsneuroinflammationsynapsis

Substanzen

AcrylamidesAmyloid beta-PeptidesAmyloid beta-Protein PrecursorHistone Deacetylase InhibitorsHistone DeacetylasesPhenylenediaminesHistone Deacetylase 3RGFP966

Autor:innen und Institutionen

  • Department of Brain Sciences, Imperial College London, Hammersmith Hospital, London, UK.
  • Department of Neuroscience, The Ohio State University, Columbus, Ohio, USA.
  • Department of Plastic and Reconstructive Surgery, The Ohio State University, Columbus, Ohio, USA.

ORCID-Profile: Nicola Davis, Laura Abelleira-Hervas, Robertas Aleksynas, Nelofer Syed, Simone Di Giovanni, Ilaria Palmisano, Magdalena Sastre

Zitieren

APA

Davis, N., Taylor, B., Abelleira-Hervas, L., Karimian-Marnani, N., Aleksynas, R., Syed, N., Di Giovanni, S., Palmisano, I., & Sastre, M. (2024). Histone deacetylase‐3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models. The FASEB Journal, 38(10). https://doi.org/10.1096/fj.202301762rr

Vancouver

Davis N, Taylor B, Abelleira-Hervas L, Karimian-Marnani N, Aleksynas R, Syed N, et al. Histone deacetylase‐3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models. The FASEB Journal. 2024;38(10). doi:10.1096/fj.202301762rr

BibTeX
@article{Davis2024,
  author = {Davis, Nicola and Taylor, Ben and Abelleira-Hervas, Laura and Karimian-Marnani, Najmeh and Aleksynas, Robertas and Syed, Nelofer and Di Giovanni, Simone and Palmisano, Ilaria and Sastre, Magdalena},
  title = {Histone deacetylase‐3 regulates the expression of the amyloid precursor protein and its inhibition promotes neuroregenerative pathways in Alzheimer's disease models},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {10},
  doi = {10.1096/fj.202301762rr}
}
Kostenlos starten →